Page 212 - Mart 2019

Haber

Ankara Onkoloji Eğitim ve Araştırma Hastanesi’nde

Faz 1 Kanser Klinik Araştırma Merkezi Açıldı

Sağlık Bilimleri Üniversitesi (SBÜ) Dr. Abdurrahman Yurtaslan Onkoloji Eğitim ve Araştırma
Hastanesi bünyesinde ‘Faz 1 Kanser Klinik Araştırma Merkezi’ hizmete girdi. Açılışta konuşan
Başhekim Prof. Dr. Fevzi Altuntaş, kanser hastalarının yeni ilaçlara erişimine imkan verecek mer-
kezle Türkiye’nin kanser alanında bir ilki gerçekleştirdiğini belirterek, “Bundan sonraki süreçte
yerli ve milli ilaçların kanser alanında üretimini sağlayacağız. Kanser öyle bir hastalık ki standart
tedaviyi tüketmiş hastaların yeni tedaviye ulaşmalarını sağlamak lazım. Yerli ve milli ilaçların
gelişimini yeni tedaviye ulaşım açısından bir şans ve fırsat olarak görmek lazım” dedi. İlaç ve Tıbbi
Cihaz Kurumu Başkanı Hakkı Gürsöz ise “En fazla klinik araştırmalar ABD›de yapılıyor. İkinci
sırada Almanya, üçüncü sırada Kanada yer alıyor. Bizim de o yolda yürümemiz gerekiyor.” dedi.

Ankara Oncology Training and Research Hospital

Phase 1 Cancer Clinical Research Center Opens

Phase 1 cancer clinical research center was put into ranks third. We need to walk on that road too.”
service by Health Sciences University Dr. Abdurrahman The center has a great importance because it is the
Yurtaslan Oncology Training and Research Hospital. Chief first phase 1 cancer clinic research center of Turkey. Chief
Physician Prof. Dr. Fevzi Altuntaş who speaks at the ope- Physician Prof. Dr. Fevzi Altuntaş who speaks at the ope-
ning, states that Turkey has achieved a “first” in the field ning, states that Turkey has achieved a “first” in the field
of cancer with the center which will allow cancer patients of cancer with the center which will allow cancer patients
to access new drugs, “In the next period, we will provide to access new drugs and said, “In the next period, we will
the production of domestic and national drugs in the field provide the production of domestic and national drugs in
of cancer. Cancer is such a disease that it is necessary to the field of cancer. Cancer is such a disease that it is neces-
ensure the patients who have exhausted the standard tre- sary to ensure the patients who have exhausted the standard
atment should access to new treatments. It is necessary to treatment should access to new treatments. It is necessary
consider the development of domestic and national drugs to consider the development of domestic and national drugs
as a chance and opportunity in terms of access to new tre- as a chance and opportunity in terms of access to new treat-
atment.” President of Pharmaceuticals and Medical Devi- ment. We want to contribute to the development of all kinds
ces Institution Hakkı Gürsöz said “Most clinical trials are of medications from breast, stomach, intestine, lymph node
performed in the USA. Germany ranks second and Canada cancer to bone marrow, head and brain cancers.”

210 Mart 2019